HIGHLIGHTS from SABCS: Racial disparities in breast cancer - Identifying predisposing clinical and molecular features associated with African American patients

HIGHLIGHTS from SABCS: APHINITY Trial - Clinical Benefit in Operable HER2-positive Early Breast Cancer patients

HIGHLIGHTS from SABCS: KEYNOTE-522 - Neoadjuvant and Adjuvant Treatment with Pembrolizumab Improves PCR for TNBC

HIGHLIGHTS from SABCS: Opposite Effects on Breast Cancer Incidence with Estrogen and Estrogen Plus Progestin

HIGHLIGHTS from SABCS: Combining Atezolizumab with Neoadjuvant Chemotherapy Does Not Improve Pathologic Complete Response Rates for Patients with Triple-Negative Breast Cancer